Pages tagged "FDA"

ASA Submits Recommendations to FDA for International Rescheduling of Cannabis

| April 23, 2018 |

This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis...

Read more

Congress Must Act to Reclassify Cannabis Under Federal Law

| August 11, 2016 |

Today, the Drug Enforcement Administration (DEA) released its decision to keep cannabis in its current Schedule 1 status. This decision will have substantial implications for the two million patients that currently have access to medical cannabis and cannabis products under state laws. Schedule I...

Read more

ASA’s “8-Factor Analysis” Calls for the Federal Removal of Cannabis from Schedule I

| June 30, 2016 |

Today, Americans for Safe Access (ASA) disseminated copies of an independent 8-Factor Analysis conducted in support of current petitions requesting removal of cannabis (marijuana) from Schedule I status in the Controlled Substances Act (CSA). The document was sent to all...

Read more

California Medical Association Says U.S. Has “Failed Public Health Policy” on Medical Marijuana, Urges Rescheduling

| October 19, 2011 |

The first broad marijuana policy statement by a state medical association has become a hot topic of conversation, repeatedly referring to the current federal approach as a “failed public health policy.” Indeed, the October 14, 2011 official policy statement by...

Read more

Research Approved to Study Effects of Medical Marijuana on PTSD

| September 15, 2011 |

           After a lengthy approval process, the Food and Drug Administration (FDA)  has granted research to study the effects of medical marijuana on people living with Post Traumatic Stress Disorder (PTSD). This summer, the research group MAPS was given the go-ahead...

Read more